Twenty-eight percent of reactions were associated with antibiotics, particularly the sulfonamide class of drugs, researchers from Vanderbilt University Medical Center in Nashville, Tenn., and the University of Toronto in Canada found.
Nearly 3,000 patient cases from 38 studies were analyzed and examined for risk factors of the severe skin reactions. Sulfonamide and penicillins were the two leading classes of antibiotics implicated in most cases.
“These findings highlight the importance of antibiotic stewardship, clinician education and awareness, and weighing the risk-benefit assessment of antibiotic choice and duration,” researchers wrote.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.